It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
BACKGROUND: The aim of this study was to assess the effects of percutaneous bilateral renal
artery stenting in patients with atherosclerotic renal artery stenosis and in-hospital and
4 month outcome of the procedure, focusing on the changes in renal function and blood pressure.
METHODS: Five consecutive patients (mean age: 64.8 ± 9.7 years, 1 women) with bilateral
renal artery stenoses underwent percutaneous interventions. We compared blood pressure,
number of oral antihypertensive medications, and renal function changes preprocedure and
postprocedure at 4 months follow-up.
RESULTS: A total of 5 bilateral atherosclerotic renal artery stenosis patients underwent
percutaneous transluminal renal angioplasty and 10 stents were placed. Although systolic and
diastolic blood pressures were significantly decreased in follow-up period, glomerular filtration
rates were not significantly changed as compared with baseline data (p = 0.009, p = 0.008,
p = 1.00, respectively). Also, the number of oral antihypertensive medications were significantly
decreased at follow-up period (p = 0.03).
CONCLUSIONS: Bilateral renal artery stenting provides a beneficial outcome such as
stabilization of renal functions, significant improvement in blood pressure control and
reduction in the number of oral antihypertensive medications at follow-up.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer